News
EU approves AstraZeneca’s Calquence in combo with venetoclax, with or without obinutuzumab to treat adult patients with previously untreated CLL: Cambridge, UK Saturday, June 7, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback